EFIB is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy. Industrial Biotechnology is currently worth €23 billion representing just 6% in sales of the overall worldwide chemicals market. However, it is significantly out-performing the overall chemicals market at an impressive 20% annual growth rate and has the potential to become the dominant technology of tomorrow’s chemicals industry, representing a huge future opportunity.
Paolo La Scola, NOVAMONT’s EU Public Affairs, representing the
FIRST2RUN project in the session “Investing in Innovation”, dedicated to the presentation of the successful projects that have received funding by the Bio-Based Industries Joint Undertaking (BBI).